ENTPD1 and head and neck squamous cell carcinoma: Saliva-derived exosomal CD44v3, a glycoprotein commonly overexpressed in HNSCC tissues (46, 47) and involved in tumor progression (46, 48), and the ectonucleotidase CD39, an enzyme involved in adenosine production (49), were significantly elevated in HNSCC patients.